Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Trade accounts payable 4.89 5.15 5.87 6.19 5.86
Salaries, wages and commissions 2.01 2.09 2.18 2.09 2.16
Accrued rebates payable to government agencies 0.79 0.76 0.89 0.86 0.48
Accrued other rebates 1.45 1.35 1.49 1.46 1.44
All other 4.47 4.21 5.03 5.53 4.97
Other accrued liabilities 6.70% 6.32% 7.41% 7.85% 6.89%
Dividends payable 1.27 1.26 1.30 1.19 1.11
Income taxes payable 0.66 0.73 0.67 0.46 0.41
Current portion of long-term debt 3.50 1.84 1.48 3.02 1.00
Current liabilities 19.02% 17.39% 18.90% 20.81% 17.43%
Long-term debt, excluding current portion 11.41 15.51 18.57 19.51 23.00
Defined benefit pension plans and post-employment medical and dental plans for significant plans 2.45 2.31 2.68 2.40 3.64
Net unrecognized tax benefits 1.61 1.05 0.00 0.00 0.00
Deferred income taxes 0.64 0.63 0.78 1.33 1.85
Operating lease liability, non-current 1.07 1.10 1.30 1.27 1.27
All other 2.93 3.18 4.73 5.11 4.90
Post-employment obligations and other long-term liabilities 8.71% 8.27% 9.49% 10.11% 11.66%
Long-term liabilities 20.12% 23.77% 28.06% 29.61% 34.67%
Total liabilities 39.14% 41.16% 46.97% 50.42% 52.09%
Preferred shares, one dollar par value, none issued 0.00 0.00 0.00 0.00 0.00
Common shares, without par value 29.44 30.90 33.97 33.19 32.54
Common shares held in treasury, at cost -19.81 -20.69 -21.83 -20.46 -15.72
Earnings employed in the business 57.41 58.05 51.29 47.36 41.93
Accumulated other comprehensive loss -6.92 -9.71 -10.71 -10.82 -11.14
Total Abbott shareholders’ investment 60.12% 58.55% 52.73% 49.28% 47.61%
Noncontrolling interests in subsidiaries 0.74 0.29 0.31 0.29 0.30
Total shareholders’ investment 60.86% 58.84% 53.03% 49.58% 47.91%
Total liabilities and shareholders’ investment 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

The composition of liabilities and shareholders’ investment experienced notable shifts between 2021 and 2025. Overall, the proportion of total liabilities decreased while the proportion of total shareholders’ investment increased over the five-year period.

Current Liabilities
Current liabilities as a percentage of the total initially rose from 17.43% in 2021 to a peak of 20.81% in 2022, before declining to 17.39% in 2024. A subsequent increase to 19.02% was observed in 2025. Within current liabilities, trade accounts payable exhibited a gradual decrease from 5.86% to 4.89%, while accrued rebates payable to government agencies nearly doubled from 0.48% to 0.79%. Income taxes payable also showed an increasing trend, rising from 0.41% to 0.66%. The current portion of long-term debt demonstrated significant volatility, peaking at 3.02% in 2022 before falling to 1.84% in 2024 and then rising again to 3.50% in 2025.
Long-Term Liabilities
Long-term liabilities decreased consistently from 34.67% in 2021 to 20.12% in 2025. This decline was primarily driven by a reduction in long-term debt, excluding the current portion, which fell from 23.00% to 11.41%. Defined benefit pension plans and post-employment medical and dental plans also decreased, though less dramatically, from 3.64% to 2.45%. Net unrecognized tax benefits were not present in the earlier years but grew to 1.61% by 2025. Deferred income taxes showed a consistent decline from 1.85% to 0.64%.
Shareholders’ Investment
Total shareholders’ investment increased from 47.91% in 2021 to 60.86% in 2025. Common shares, without par value, decreased as a percentage of the total from 32.54% to 29.44%. Common shares held in treasury also decreased, but remained a significant negative percentage, moving from -15.72% to -19.81%. The most substantial change within shareholders’ investment was the increase in earnings employed in the business, which rose from 41.93% to 57.41%. Accumulated other comprehensive loss decreased from -11.14% to -6.92%, contributing to the overall increase in shareholders’ investment. Noncontrolling interests in subsidiaries remained relatively stable, with a notable increase to 0.74% in 2025.
Total Liabilities
Total liabilities decreased from 52.09% in 2021 to 39.14% in 2025, reflecting the declines observed in both current and long-term liabilities. This decrease suggests a shift towards financing operations through equity rather than debt.

The observed trends indicate a strengthening of the shareholders’ equity position relative to liabilities, potentially reflecting improved profitability and financial stability. The fluctuations within specific liability accounts warrant further investigation to understand the underlying business drivers.

AI Ask an analyst for more